AstraZeneca
AstraZeneca is a global biopharmaceutical company known for its innovative medicines, particularly in the fields of oncology, cardiovascular, renal, and respiratory diseases. Recently, the company announced a significant investment of $2.5 billion to establish a global strategic research and development center in Beijing.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
China:
AstraZeneca announced plans to invest over 100 billion yuan in China by 2030 to expand its pharmaceutical production.
7
Hong Kong:
AstraZeneca announced plans to invest over 100 billion yuan in China by 2030.
8
Costa Rica:
AstraZeneca announced multimillion-dollar investments in the United States, committing to reduce their fees in exchange for tariff exemptions.
6
China:
AstraZeneca announced an additional investment of $136 million to expand its production capacity in Qingdao.
7
Russia:
AstraZeneca insists on the legality of its existing patent and its rights to the drug.
6
China:
AstraZeneca announced a $2.5 billion investment plan to establish a global strategic R&D center in Beijing.
9
Hong Kong:
AstraZeneca announced an investment of $2.5 billion to establish a global strategic R&D center in Beijing.
7